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ABSTRACT. The aim of this study was to develop and validate a high performance liquid chromatography 
(HPLC) method for the determination of thirteen selected pharmaceutical compounds (metformin, amoxicillin, 
chloroquine, theophylline, trimethoprim, caffeine, norfloxacin, ciprofloxacin, acetylsalicylic acid, doxycycline 
hyclate, metronidazole, albendazole and cloxacillin) in bulk and tablet dosage form. Chromatographic separation 
using a Kromasil C18 column, gradient elution with aqueous formic acid (0.1%), methanol and acetonitrile, a UV 
absorption wavelength of 250 nm and a mobile phase flow rate of 1 mL/min over a 22 min run time was optimized 
for complete separation of the selected target compounds. The method was validated and results for: linearity, 
precision, sensitivity, accuracy, specificity, suitability and method robustness were obtained and met the ICH 
guidelines. Calibration curve correlation coefficients ranged from 0.99850.9998 and the percentage relative 
standard deviations for repeated analysis was below 5%, indicating acceptable method precision. The limits of 
detection (LODs) and quantification (LOQs) ranged from 0.0200.27 µg/L and 0.0800.91 µg/L, respectively. 
The accuracy study yielded recoveries in the ranges 86.0102% for pure compounds and 90.9106% for 
compounds in tablet dosage form. The method is robust for small or deliberate changes to the chromatographic 
parameters and found to be appropriate for analysis of tablets for the determination of the thirteen 
pharmaceuticals. 
  
KEY WORDS: Pharmaceuticals, Bulk determination, Tablet dosage, High performance liquid chromatography, 
Method development, ICH guidelines 
INTRODUCTION 
 
Pharmaceuticals are synthetic or natural chemicals that are used extensively in human and 
veterinary medicine to prevent illness. They are also used as growth promoters that contain 
active ingredients designed to have pharmacological effects and confer significant benefits [1, 
2]. After administration, a part of the consumed pharmaceuticals is excreted as metabolites and 
unchanged parent compounds largely through the urine and feces [3]. Classification of 
pharmaceuticals into various classes may be based on their pharmacological properties, such as 
their therapeutic effects. Those selected for this study are frequently prescribed drugs that are 
also detected in the environment. 
Antibiotics are natural, semi-synthetic or synthetic drugs used as antibacterial, antifungal or 
anti-parasitic agents and are important medicines [4]. Widely used antibiotics include 
amoxicillin  (AMOX), which  is used to combat bacterial infections [5], and ciprofloxacin (CIP) 
a synthetic fluoroquinolone derivative with broad-spectrum activity against many pathogenic 
gram-positive bacteria [6]. Cloxacillin (CLA) belongs to the semi-synthetic β-lactam antibiotics 
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used against staphylococci that produce beta-lactamas [7], while doxycyclinehyclate (DOXH), a 
broad spectrum tetracycline antibiotic with a large range of antibacterial activities [8]. A 
member of the fluoroquinolones third-generation antibiotics, norfloxacine (NOR), is used for the 
treatment of diseases caused by Campylobacter, Escherichia coli, Shigella and Vibrio cholera 
and used to treat gonorrhea and urinary tract infection [9]. The antibiotic trimethoprim (TMP) is 
used for protozoal infections [10], while metronidazole (MTZ) is prescribed for treatment and 
prophylaxis of anaerobic bacterial infections and specific bacterial infections [11]. 
Anthelminthics are drugs that are used to eject parasitic worms from the gastro-intestinal 
tract by either stunning or  killing them [12]. Albendazole (ABZ) is one of several broad-
spectrum benzimidazole parasiticides used for treatment of parenchymal neurocysticercosis 
[13]. 
Anti-malarial drugs such as chloroquine (CHQ) are used for treating fever caused by 
malaria. Chloroquine is also prescribed to decrease the symptoms of rheumatoid arthritis and to 
treat systemic and discoidlupus erythematosus in adults [14]. 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for treatment of fever, pain and 
inflammation. Acetyl salicylic acid (ASA), also known as aspirin, with the chemical name 2-
acetoxybenzoic acid, is one of the most widely used drugs in the world and exerts analgesic, 
antipyretic and anti-inflammatory effects [15, 16]. 
Central nervous system stimulants are a group of drugs that produce an increase in mental 
and motor activity. 1,3,7-Trimethylxanthine, commonly referred to as caffeine (CAF) acts as a 
stimulant psychotrope and as a mild diuretic [17], while theophylline (THP) displays anti-
inflammatory activities by inhibiting the activity of CD4 lymphocytes in vitro and through 
mediator release from mast cells [18].  
Anti-diabetic metformin (MET) is used in the treatment of diabetes mellitus II, since it 
suppresses the production of hepatic glucose, and thus attenuates hyperglycemia [19].  
Many authors have described the determination of pharmaceuticals in pure, tablet dosage 
form and real sample using a range of analytical techniques. Analytical techniques including 
liquid chromatography (LC) and gas chromatography (GC) are commonly employed for the 
separation and determination of compounds in mixtures, but liquid chromatography is mostly 
used to determine pharmaceuticals, since they are mostly non-volatile [20, 21]. Liquid 
chromatographic methods for amoxicillin [22], alebendazole [23], chloroquine [24], 
acetylsalicylic acid [16], caffeine [25], metronidazole [26], theophylline [27] and ciprofloxacin 
[28] have been reported. Spectrophotometric methods for amoxicillin [29], cloxacilln [30], 
ciprofloxacin [31], trimethoprim [32], albendazole [23], chloroquine [33], metronidazole [26] 
and for metformin [34] has been reported. Electrochemical methods for metronidazole [35], 
caffeine and theophylline [36], albendazole [37] and acetylsalicylic acid [38]; a kinetic method 
for amoxicillin [5] and a method using chemiluminescence for norfloxacin [39] are available in 
literature. 
To the best of our knowledge there is no single HPLC method reported for the simultaneous 
determination of these selected pharmaceutical compounds of different therapeutic classes. This 
study attempts to develop a simple, accurate, precise and stable analytical chromatographic 
method, which can separate and determine thirteen selected pharmaceutical drugs 
simultaneously in a single optimized method in bulk and commercial tablet dosage form. The 
proposed method has been developed and validated as per the ICH guidelines for the analysis. 
Developing such an analytical method is more cost-effective than changing parameters for each 
analyte for the analysis of real samples. The developed method is suitable for laboratories that 
are not equipped with highly specialized state-of-the-art instrumentation. The method will still 




Development of a single HPLC method for the determination of thirteen pharmaceuticals   




Chemicals, reagents and equipment 
 
All the chemicals used for method development were analytical grade. The HPLC grade 
methanol (>99%) and HPLC grade acetonitrile (>99.9%) were from Fisher Scientific (UK), the 
formic acid (>96%) from Sigma Aldrich (Germany) and acetic acid (99%) from Fisher 
Chemicals (UK). Ultra-pure water used throughout the study was generated using a Millipore 
system (Direct-Q 3 UV with pump, South Africa). Pharmaceutical standard compounds 
(assigned purity ≥99%), listed in Table 1, were a kind donation from Addis Pharmaceuticals 
(Adigrat, Ethiopia) and tablets containing the target active compound were purchased from the 
local market in Addis Ababa, Ethiopia. Chromatographic separation was performed on an 
Agilent HPLC 1260 Series equipped with quaternary pump, auto sampler and diode array 
detectorfrom Agilent Technologies (Singapore, Germany). Data acquisition and processing were 
accomplished with LC Chemstation software (Agilent Technologies). 
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Chromatographic separation  
 
Chromatographic separation of the thirteen selected pharmaceutical compounds was achieved 
using a Kromasil C18, 5 µm (4.6 mm x 150 mm x 5 µm) column (Sigma Aldrich, (Stockholm, 
Sweden) held at ambient temperature. A combination of 0.1% aqueous formic acid, acetonitrile 
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detect at 250 nm UV absorbance. An aliquot of 10 μL of a mixture of the selected compounds 
were injected into the system. The total run time was 22 min. 
 
Preparation of standard solutions 
 
Mixed stock solutions of twelve pharmaceutical standards (200 µg/mL) were prepared by 
dissolving 10 mg with ultra-pure water/methanol (50:50, v/v) in 50 mL volumetric flask. A 
stock solution of ciprofloxacin, which is insoluble in methanol, was dissolved in ultra-pure 
water (200 µg/mL) and stored in the refrigerator. Series of working standard solutions for the 
method development were prepared daily with a mixture of ultra-pure water/methanol (90:10, 
v/v). 
 
Preparation of tablet sample solutions  
 
For the preparation of the sample solutions used for method validation, an accurately weighed 
amount of powder equivalent to 10 mg of each tablet was transferred completely to a 50 mL 
volumetric flask and dissolved with ultra-pure water/methanol (50:50, v/v). The ciprofloxacin 
powdered tablet was dissolved in ultra-pure water only. All the tablet powders were sonicated in 
the solvent for about 30 min and then filtered through Whatman filter paper number 1 (110 
mm). The volume was adjusted to 50 mL followed by filtration through a 0.22 μm membrane 
filter. Mixtures of series of sample solutions were prepared by dissolving with ultra-pure water 
and methanol (90:10, v/v). 
 
Parameter optimization  
 
Separation in liquid chromatography is highly affected by different factors including mobile 
phase (both solvent type and composition), the addition of additives, absorption wavelength and 
mobile phase flow rate. Different solvents (water, acetonitrile and methanol) and additives 
(formic acid and acetic acid) were evaluated for the separation of thirteen pharmaceutical 
compounds. The mixed standard solution was scanned in the wavelength region of 190–400 nm 
for wavelength selection for proper separation. The effect of mobile phase flow rate was also 
investigated using a different flow rate of 0.6, 1 and 1.3 mL/min. The chromatographic 
parameters were evaluated by taking both the resolution and symmetry of the peaks into 
account. 
 
Validation of the analytical method 
 
The developed method for the determination of selected pharmaceuticals was evaluated as per 
the ICH Q2 [40] guidelines protocol for, linearity, sensitivity, precision, accuracy, specificity, 
robustness, and system suitability. 
 
RESULTS AND DISCUSSION 
 
Mobile phase and additive selection  
 
The mobile phase was selected according to the physico-chemical properties of pharmaceutical 
drugs to provide good separation. Separation in liquid chromatography is highly affected by 
mobile phase, both solvent type and composition. Different solvents (water, acetonitrile and 
methanol) and additives (formic acid and acetic acid) were evaluated. From the examined 
mobile phase composition and additives, a combination of formic acid in water, acetonitrile and 
methanol resulted in the best resolution and a short run time. The effect of the concentration of 
Bisratewongel Tegegne et al. 
Bull. Chem. Soc. Ethiop. 2021, 35(1) 
22
formic acid in the water on separation was also examined and 0.1% formic acid yielded the best 
resolution between analytes. The composition of the solvent was evaluated by taking both the 
resolution and symmetry of the peak into account. The optimum mobile phase comprised three 
solvents. Separation of the analytes was accomplished over 22 min using gradient elution with 
A (water with 0.1% formic acid), B (acetonitrile) and C (methanol). The gradient was applied as 
follows: program, 90-50% A, 1-20% B and 9-30% C (8 min), held at 50% A, 20 % B and 30% 
C (7 min) before changing to 50-30% A, 20-50% B and 30% C (2 min), to 30-5% A, 50-90% B, 
30-5% C (3 min) and finally, to 5-90% A, 90-1% B and 5-9% C (2 min).  
 
Wavelength selection  
 
The optimum wavelength should be the one which shows good absorbance for all the selected 
compounds. The mixed standard solution was scanned in the wavelength region of 190–400 nm. 
It is evident from Figure 1 that 250 nm yielded the largest overall relative peak height for all the 
analytes compared to those obtained at 240 nm, 270 or 340 nm. It should be noted that Table 1 
shows that three compounds (amoxicillin, metronidazole and chloroquine) have a maximum UV 
absorption at 340 nm or close to 340 nm. However, Figure 1 shows that only chloroquine had a 
good absorbance at 340 nm while amoxicillin and metronidazole do not had good absorbance at 
340 nm. This is because the absorbance of a compound depends on the type of solvent, 
concentration and molar absorptivity. This indicates that amoxicillin and metronidazole have 
smaller molar absorptivity in the solvent used. No absorption of amoxicillin and metronidazole 
at 340 nm may also be due effect of the other compounds present in the mixture. Therefore, 250 
nm was selected as an optimum wavelength at which all the thirteen compounds showed good 
absorbance. It should also be noted that using a wavelength of 250 nm (the selected wavelength) 
would certainly diminish the sensitivity of the detector towards analytes with UV max above 
300 nm. Although this would not really matter for pharmaceutical products containing high 
concentrations of the active ingredient, since the analytes are easily detected, small differences 
in concentrations would not be picked up for these compounds. 
 
 
Figure 1. Detector response of 13 selected pharmaceutical drugs analysed using four different 
UV wavelengths to enable selection of the optimal wavelength. 
 
Mobile phase flow rate optimization  
 
The interaction of the compound with the stationary and the mobile phase affects the resolution 
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in flow rate (1.3 mL/min) decreased the retention time of all analyte compounds, it adversely 
affected the resolution of some compounds. A faster mobile phase flow limits the interaction of 
analyte with the stationary phase. While decreasing the flow rate (0.6 mL/min) increased the 
retention times and total run time, it caused and leads to broadening of the peaks and yielded 
poorly resolved peaks, compared to 1.0 mL/min which was selected as optimum flow rate 
(Figure 2). In this study the first peak, which was due to the elution of metformin, was 
controlled by avoiding contamination with frequent injection in the system by running the blank 
after each run. 
 
(1(Metformin), 2(Amoxicillin), 3(Chloroquine), 4(Theophylline), 5(Trimethoprim), 6(Caffeine), 
7(Norfloxacin), 8(Ciprofloxacin), 9(Acetyl salicylic acid), 10(Doxycycline hyclates), 11(Metronidazole), 
12(Albendazole), 13(Cloxacillin)) 
 
Figure 2. Chromatograms obtained using different mobile phase flow rates (a) 0.6 mL/min, (b) 1 
mL/min and (c) 1.3 mL/min. 
 




The ability of the assay to give data that is directly proportional to the concentration of analyte 
that the sample contains is referred to as linearity. Similarly, the range refers to the highest and 
lowest concentration of the analyte that can be detected by the detector of the method with an 
appropriate accuracy, precision, and linearity [41]. The linearity of the method measured as peak 
areas against the corresponding concentrations of the analyte compounds were evaluated using 
the correlation coefficients (R2) as reported in (Table 2). 
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Table 2. Linear range, regression equation and correlation coefficient for each of the 13 selected 
pharmaceuticals when using the developed method. 
 
Pharmaceutical compound  Linear range 
(µg/mL) 
Regression equation R2 
Acetyl salicylic acid  1.0 - 100 y = 3.6181x + 1.3002 0.9998 
Albendazole 0.50 - 100 y = 8.8529x + 13.169 0.9988 
Amoxicillin  2.5 - 100 y = 2.4260x + 0.2300 0.9998 
Caffeine 0.50 - 100 y = 10.167x + 6.0284 0.9996 
Chloroquine  0.50 - 100 y = 11.150x + 7.5555 0.9997 
Ciprofloxacin 1.0 - 100 y = 9.8126x +5.7892 0.9987 
Cloxacillin 0.70 - 100 y = 3.422x + 2.7597 0.9991 
Doxycycline hyclates 1.0 - 100 y = 0.9325x + 5.5146 0.9987 
Metformin  0.50 - 100 y = 9.0233x + 7.2918 0.9993 
Metronidazole 1.0 - 100 y = 4.4886x + 9.6939 0.9985 
Norfloxacin 0.70 - 100 y = 7.5441x + 1.4492 0.9998 
Theophylline  0.50 - 100 y = 11.644x + 8.8687 0.9994 




The limits of detection (LOD) and limits of quantification (LOQ) for each of the analytes were 
calculated from the standard deviation of the response and slope of the calibration curve of 
pharmaceutical compounds using the formula as per ICH guideline, 3.3σ/s and 10σ/s, 
respectively, where σ is the standard deviation of the response and s the slope of the calibration 
curve. The results are reported in Table 3, which shows that the LODs ranged from 0.020.27 
µg/L and the LOQs from 0.080.91 µg/L. 
 
Table 3. LODs, LOQs and precision obtained for the method developed for the simultaneous 
determination of selected pharmaceutical compounds. 
 






(%RSD, n = 3) 
Reproducibility 
(%RSD, n = 3) 
Acetyl salicylic acid 0.070 0.23 2.8 5.1 
Albendazole 0.040 0.15 1.7 4.3 
Amoxicillin  0.27 0.91 1.2 4.9 
Caffeine 0.020 0.08 1.1 2.0 
Chloroquine  0.030 0.12 1.4 3.3 
Ciprofloxacin 0.030 0.09 1.2 5.1 
Cloxacillin 0.16 0.53 1.3 2.6 
Doxycycline hyclates 0.16 0.54 3.1 3.9 
Metformin  0.15 0.33 3.0 5.2 
Metronidazole 0.10 0.58 1.3 3.9 
Norfloxacin 0.080 0.27 1.7 4.1 
Theophylline  0.050 0.16 1.4 3.1 




The precision of the developed method was evaluated by performing intra-day and inter-day 
precision studies using a concentration of 1 µg/mL of each analyte in solution. The measured 
peak areas were used to calculate the percent relative standard deviations (%RSDs). Intra-day 
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precision was carried out by analysing three replicates of a mixture of the standard 
pharmaceuticals on the same day. The measured peak areas were used to calculate the 
percentage relative standard deviations (%RSDs). The inter-day precision study was performed 
on three consecutive days by analyzing the mixture of all thirteen pharmaceutical drugs in 
triplicate and the % RSDs were calculated (Table 3). The result obtained for the precision study 
were regarded as acceptable for analysis, due to the small % RSDs that ranged from 1.1-5.3%, 
which were lower than the stipulated values of 15% [42]. 
 


















50 % 86.8  
86.3±1.0 
89.4  
90.9±10 100 % 85.2 81.4 
150 % 87.0 102 
 
Albendazole 
100% 89.7  
93.8±7.7 
89.2  
95.1±5.2 150% 103 97.8 
150% 89.0 98.5 
 
Amoxicillin 





100% 86.0 93.0 
150% 85.5 98.5 
 
Caffeine 
50 % 92.5  
93.5±1.7 
83.1  
91.9±8.2 100% 92.6 99.4 
150% 95.6 93.1 
 
Chloroquine  
50 % 88.7  
87.9±2.4 
93.7  
94.9±11 100% 85.2 107 




50 % 89.9  
102±10 
89.4  
97.4±7.0 100% 105 103 
150% 111 100 
 
Cloxacillin 
50 % 96.0  
92.2±3.5 
110  
106±4.0 100% 89.0 104 
150% 91.6 103 
 
Metformin 
50 % 89.4  
87.5±1.7 
105  
105±1.7 100% 87.2 104 
150% 85.9 107 
Doxycycline 
hyclates 
50 % 108  
100±7.6 
117  
101±9.6 100% 93.7 95.2 
150% 97.9 94.7 
 
Metronidazole 
50 % 94.8  
101±10 
115  
104±12 100% 113 90.1 
150% 95.5 106 
 
Norfloxacin 
50 % 85.6  
95.3±9.2 
98  
99.6±9.2 100% 96.3 109 
150% 104 91.3 
Theophylline  50 % 85.2  
87.9±2.8 
103  
101±6.1 100% 87.6 105 
150% 90.9 93.8 
 
Trimethoprim 
50 % 86.5  
86.3±0.8 
108  
98.5±11 100% 85.4 102 
150% 86.9 85.8 
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To study the accuracy of the proposed method, recovery studies were carried out by applying 
standard addition at three different levels. A known amount of the mixture of pharmaceutical 
compounds (50%, 100% and 150%) of 10 mg/L was added to a pre-analyzed standard and 
sample solution. The percentage recoveries were calculated as reported in Table 4. Recoveries 
ranged from 86.0–102% for pure compounds and from 90.9–106% for tablet dosage forms, 
which are within the acceptable range [42]. The preparation of the solution and the ingredients 





The specificity of the developed HPLC method was established by injecting the blank (solvent) 
and placebo solution without active pharmaceutical ingredient, into the HPLC system using the 
optimized conditions. The representative chromatogram of blank and placebo is shown in Figure 
3 (a) and (b), respectively. No peaks were detected at the retention times corresponding to any 
of the target analytes considered in this study. 
 
 





The robustness of an analytical procedure refers to its capability to remain unaffected by small, 
but deliberate variations in method parameters [43] and provides an indication of its reliability 
during application. Robustness of the developed method was investigated after minor 
modifications of conditions including changes to the flow rate of the mobile phase, percent of 
additive (formic acid) in the mobile phase, and detector wavelength for absorption. The results 
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(Table 5) revealed that the developed method is robust, and the peaks are well separated and 
elute with acceptable symmetry and resolution. 
 
Table 5. Results of the method robustness tests. 
 
Compounds Parameters changed for robustness study 
Flow rate (mL/min) Wavelength (nm) % Formic acid 
 0.8 1.0 1.2 248 250 252 0.05 0.1 0.15 
Albendazole Peak 
symmetry  
1.116 0.913 0.879 0.379 0.913 0.927 1.077 0.913 0.919 
% RSD  0.362 1.731 3.267 1.971 1.731 2.962 0.166 1.731 2.146 
Rt (min) 16.03 16.17 15.55 16.07 16.17 16.08 16.18 16.17 16.62 
Amoxicillin  Peak 
symmetry 
0.883 0.218 0.911 0.585 0.218 0.47 0.903 0.218 0.837 
% RSD  0.557 1.205 3.566 0.838 1.205 3.077 2.722 1.205 2.939 





1.038 0.995 1.091 1.26 0.995 0.782 0.912 0.995 1.100 
% RSD  4.641 2.778 2.158 1.794 2.778 2.963 3.608 2.778 0.307 
Rt (min) 11.53 11.51 11.11 11.42 11.51 11.50 11.16 11.51 11.12 
Caffeine Peak 
symmetry 
0.960 0.995 0.988 0.988 0.995 0.995 0.611 0.995 1.005 
% RSD  3.057 1.142 4.339 2.050 1.142 0.544 3.629 1.142 2.204 
Rt (min) 7.731 7.417 7.064 7.032 7.417 7.293 7.162 7.417 7.167 
Chloroquine  Peak 
symmetry 
1.735 0.676 0.630 1.46 0.676 1.592 0.650 0.676 0.393 
% RSD  3.125 1.430 3.110 2.478 1.430 0.878 0.660 1.430 1.257 





0.770 0.717 0.866 0.913 0.717 0.908 0.897 0.717 0.630 
% RSD  2.564 1.198 2.894 3.398 1.198 0.676 3.994 1.198 1.684 
Rt (min) 8.308 8.166 7.918 8.008 8.166 8.014 7.700 8.166 7.518 
Cloxacillin Peak 
symmetry 
0.911 0.925 0.912 0.270 0.925 0.968 0.948 0.925 0.856 
% RSD  3.832 1.323 3.909 2.008 1.323 0.785 3.578 1.323 2.096 
Rt (min) 19.278 19.39 18.85 19.03 19.39 18.99 19.23 19.393 19.16 
Metformin  Peak 
symmetry 
0.672 0.503 0.515 1.002 0.503 0.999 0.406 0.503 0.721 
% RSD  2.818 3.020 1.961 1.961 3.020 3.030 1.171 3.020 0.969 





0.844 0.859 0.851 0.659 0.859 0.740 0.247 0.859 0.846 
% RSD  4.545 3.104 3.040 4.140 3.104 2.433 3.101 3.104 2.674 
Rt (min) 11.76 11.82 11.56 11.52 11.82 11.45 11.78 11.82 11.35 
Metronidazole Peak 
symmetry 
1.019 0.953 1.009 0.771 0.953 1.245 0.948 0.953 1.154 
% RSD  1.742 1.294 0.754 2.286 1.294 3.116 3.838 1.294 0.881 
Rt (min) 13.11 13.19 12.67 13.04 13.19 13.01 12.24 13.19 12.33 
Norfloxacin Peak 
symmetry 
0.780 0.714 0.712 1.037 0.714 1.026 0.671 0.714 0.547 
% RSD  1.890 1.713 4.006 1.389 1.713 1.949 2.163 1.713 0.081 
Rt (min) 8.114 7.960 7.699 7.654 7.960 7.556 7.494 7.960 7.269 
Theophylline  Peak 
symmetry 
0.963 0.942 1.003 0.792 0.942 0.783 0.637 0.942 0.952 
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% RSD  1.141 1.414 2.710 1.916 1.414 1.068 2.850 1.414 0.816 
Rt (min) 6.616 6.242 5.853 5.934 6.242 6.103 5.950 6.242 5.972 
Trimethoprim Peak 
symmetry 
0.772 0.691 0.701 1.021 0.691 1.047 0.963 0.691 0.499 
% RSD  2.578 1.269 2.277 3.044 1.269 0.544 1.292 1.269 1.263 




The system suitability test of a chromatographic method is used to verify that the 
chromatographic system is adequate for application to samples. The parameters considered for 
this test include retention time, resolution (to the adjacent peak); peak symmetry and number of 
theoretical plates. These parameters were investigated using the optimized chromatographic 
conditions. The results (Table 6) reflect good performance and acceptable levels for all the 
selected analytes. 
 




A simple, accurate, precise and robust HPLC method has been developed for the determination 
of thirteen selected pharmaceutical drugs in bulk and marketed tablet dosage form using a single 
optimized condition. The developed method was validated using ICH guidelines, which proves 
the reliability of the proposed method. The accuracy of the method was validated by percentage 
recovery and found to be in the acceptable range. The system suitability parameters were within 
limit, hence it was concluded that all the systems were suitable to perform further analysis. The 
development of such an analytical method has many advantages, since different products can be 
analysed in sequence without changing the instrumental conditions. This is a cost-effective 
approach for laboratories that lack highly specialized state-of-the-art instrumentation, since it 
streamlines the laboratory workflow. As new samples come in for quality control, they can be 











Acetyl salicylic acid  11.5 3.7 0.995 341762 
Albendazole 16.2 13 0.953 28382 
Amoxicillin  4.8 9.0 0.218 18916 
Caffeine 7.4 8.5 0.955 212283 
Chloroquine  5.9 5.0 0.676 139880 
Ciprofloxacin 8.2 47 0.717 262543 
Cloxacillin 19.4 - 0.925 2071273 
Metformin  1.3 30 0.503 13950 
Doxycycline hyclates 11.8 14.5 0.859 311071 
Metronidazole 13.2 21 0.953 251295 
Norfloxacin 7.6 3.2 0.714 250709 
Theophylline  6.2 12.5 0.942 170141 
Trimethoprim 7.0 5.8 0.691 174425 
Development of a single HPLC method for the determination of thirteen pharmaceuticals   
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